Professional
Added to YB: 2026-05-06
Pitch date: 2026-04-30
SOFW.TA [neutral]
SofWave Medical Ltd.
-12.05%
current return
Author Info
Caro-Kann Capital is a research-intensive investment firm focused on small cap stocks. Visit the website.
Company Info
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin rejuvenation and firming treatments in Israel and internationally.
Market Cap
ILS 398.0M
Pitch Price
ILS 44.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
83.82
P/E
565.43
EV/Sales
4.84
Sector
Health Care Equipment and Supplies
Category
growth
Caro-Kann Capital Portfolio Holding: SofWave Medical Ltd.
SOFW.TA (holding update): Razor-blade model, blades ~100% gross margin. Best non-invasive skin-tightening device per derms/plastic surgeons. GLP-1/Zoom/Instagram driving demand. Rev growth accelerated: 19.7%→57.8% QoQ through 4Q25. Adj EBIT margin: -2%→10.5% in FY25 (16% in Q4). Pursuing US listing to shed orphan stock status. Mgmt owns 25%, US generates >50% rev.
Read full article (2 min)